EP1015032A2 — High viscosity liquid controlled delivery system as a device
Assigned to Durect Corp · Expires 2000-07-05 · 26y expired
What this patent protects
A composition as a medical or surgical device is provided that includes: (i) a non-polymeric, non-water soluble liquid carrier material (HVLCM) of viscosity of at least 5,000 cP at 37 °C that does not crystallize neat under ambient or physiological conditions; and, optionally, (i…
USPTO Abstract
A composition as a medical or surgical device is provided that includes: (i) a non-polymeric, non-water soluble liquid carrier material (HVLCM) of viscosity of at least 5,000 cP at 37 °C that does not crystallize neat under ambient or physiological conditions; and, optionally, (ii) a substance to be delivered.
Drugs covered by this patent
- Risperdal (risperidone) · Johnson & Johnson (Janssen)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.